Cargando…

Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)

This study aimed at investigating the fecal microbiota, and the fecal and urinary metabolome of non progressor (NP) and progressor (P) patients with immunoglobulin A nephropathy (IgAN). Three groups of volunteers were included in the study: (i) sixteen IgAN NP patients; (ii) sixteen IgAN P patients;...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Angelis, Maria, Montemurno, Eustacchio, Piccolo, Maria, Vannini, Lucia, Lauriero, Gabriella, Maranzano, Valentina, Gozzi, Giorgia, Serrazanetti, Diana, Dalfino, Giuseppe, Gobbetti, Marco, Gesualdo, Loreto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055632/ https://www.ncbi.nlm.nih.gov/pubmed/24922509 http://dx.doi.org/10.1371/journal.pone.0099006

Ejemplares similares

Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals
por: Cosola, Carmela, et al.
Publicado: (2017)

Fecal Microbiota Transplantation Modulates Renal Phenotype in the Humanized Mouse Model of IgA Nephropathy
por: Lauriero, Gabriella, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Nefecon versus Best Supportive Care for People with Immunoglobulin A Nephropathy (IgAN) in the United States
por: Ramjee, Lauren, et al.
Publicado: (2023)

The molecular mechanisms of inflammation and scarring in the kidneys of immunoglobulin A nephropathy: Gene involvement in the mechanisms of inflammation and scarring in kidney biopsy of IgAN patients
por: Schena, Francesco Paolo, et al.
Publicado: (2021)

High levels of gut-homing immunoglobulin A(+) B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients
por: Sallustio, Fabio, et al.
Publicado: (2020)

High levels of gut-homing immunoglobulin A(+) B lymphocytes support the pathogenic role of intestinal mucosal hyperresponsiveness in immunoglobulin A nephropathy patients
por: Sallustio, Fabio, et al.
Publicado: (2021)

IgAN Genetic Risk Score in the Clinical Setting
por: Schena, Francesco Paolo, et al.
Publicado: (2020)

New directions in the pathogenesis of primary erythrocytosis in IgAN
por: Schena, Francesco Paolo, et al.
Publicado: (2022)

Targeting the Alternative Complement Pathway With Iptacopan to Treat IgA Nephropathy: Design and Rationale of the APPLAUSE-IgAN Study
por: Rizk, Dana V., et al.
Publicado: (2023)

Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN
por: Paunas, Flavia Teodora Ioana, et al.
Publicado: (2022)

Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis
por: Ebbestad, Robin, et al.
Publicado: (2022)

Identification of key cuproptosis-related genes and their targets in patients with IgAN
por: Lin, Huagang, et al.
Publicado: (2022)

The mucosal immune system and IgA nephropathy
por: Gesualdo, Loreto, et al.
Publicado: (2021)

The Human Virome and Its Crosslink with Glomerulonephritis and IgA Nephropathy
por: Sallustio, Fabio, et al.
Publicado: (2023)

Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)
por: Schimpf, Judith Isabel, et al.
Publicado: (2018)

Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients
por: Zand, Ladan, et al.
Publicado: (2023)

Decreased Expression of Urinary Mammalian Target of Rapamycin mRNA Is Related to Chronic Renal Fibrosis in IgAN
por: Cao, Yuhan, et al.
Publicado: (2019)

The Role of Renal Macrophage, AIM, and TGF-β1 Expression in Renal Fibrosis Progression in IgAN Patients
por: Yang, Min, et al.
Publicado: (2021)

Chemokine (C–C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children
por: Shen, Yanjie, et al.
Publicado: (2022)

APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN
por: Yu, Kuipeng, et al.
Publicado: (2023)

The Same Microbiota and a Potentially Discriminant Metabolome in the Saliva of Omnivore, Ovo-Lacto-Vegetarian and Vegan Individuals
por: De Filippis, Francesca, et al.
Publicado: (2014)

Native LDL-induced oxidative stress in human proximal tubular cells: multiple players involved
por: Piccoli, Claudia, et al.
Publicado: (2011)

A New Vision of IgA Nephropathy: The Missing Link
por: Sallustio, Fabio, et al.
Publicado: (2019)

Branchio-Oto-Renal Syndrome (BOR) associated with focal glomerulosclerosis in a patient with a novel EYA1 splice site mutation
por: Gigante, Maddalena, et al.
Publicado: (2013)

The solution structures of native and patient monomeric human IgA1 reveal asymmetric extended structures: implications for function and IgAN disease
por: Hui, Gar Kay, et al.
Publicado: (2015)

TFRC–RNA interactions show the regulation of gene expression and alternative splicing associated with IgAN in human renal tubule mesangial cells
por: Li, Jian-Si, et al.
Publicado: (2023)

Rifaximin as a Potential Treatment for IgA Nephropathy in a Humanized Mice Model
por: Di Leo, Vincenzo, et al.
Publicado: (2021)

scIGANs: single-cell RNA-seq imputation using generative adversarial networks
por: Xu, Yungang, et al.
Publicado: (2020)

Recurrence of immunoglobulin A nephropathy after kidney transplantation: a narrative review of the incidence, risk factors, pathophysiology and management of immunosuppressive therapy
por: Infante, Barbara, et al.
Publicado: (2020)

Fecal Microbiota and Metabolome of Children with Autism and Pervasive Developmental Disorder Not Otherwise Specified
por: De Angelis, Maria, et al.
Publicado: (2013)

Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis
por: Moresco, Rafael N., et al.
Publicado: (2016)

In Vitro Selection of Probiotics, Prebiotics, and Antioxidants to Develop an Innovative Synbiotic (NatuREN G) and Testing Its Effect in Reducing Uremic Toxins in Fecal Batches from CKD Patients
por: Vacca, Mirco, et al.
Publicado: (2021)

Treatment with rituximab in idiopathic membranous nephropathy
por: Fiorentino, Marco, et al.
Publicado: (2016)

A Systems Biology Overview on Human Diabetic Nephropathy: From Genetic Susceptibility to Post-Transcriptional and Post-Translational Modifications
por: Conserva, Francesca, et al.
Publicado: (2016)

Immunoglobulin A Nephropathy. Recurrence After Renal Transplantation
por: Moroni, Gabriella, et al.
Publicado: (2019)

Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience
por: Mohd, Rozita, et al.
Publicado: (2021)

A Case Report of Diffuse Alveolar Hemorrhage Coexisting With Immunoglobulin A (IgA) Nephropathy
por: Kolman, Michael, et al.
Publicado: (2022)

Integration of datasets from different analytical techniques to assess the impact of nutrition on human metabolome
por: Vernocchi, Pamela, et al.
Publicado: (2012)

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments
por: Coppo, Rosanna, et al.
Publicado: (2014)

Serum levels of galactose-deficient immunoglobulin (Ig) A1 and related immune complex are associated with disease activity of IgA nephropathy
por: Suzuki, Yusuke, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_spgknul0fe2s9td9fuk83qeo3c